HHS to allow sale of unapproved peptides under review

The Department of Health and Human Services will allow compounding pharmacies to manufacture and sell peptides that have not yet been approved, advancing the Make America Healthy Again agenda. HHS stated it would practice enforcement discretion, expanding access to these substances despite lack of FDA approval.